Voices from Biotech: Katherine Southwick, Vice President of Marketing & Communications, National Psoriasis Foundation

Despite major advances in psoriatic disease treatment, many patients remain disengaged from care — not due to lack of access, but because of stalled momentum shaped by past experiences, mistrust, and the perception that symptoms are “good enough.” This session explores new research on hard-to-reach populations and outlines how reframing messaging and rebuilding trust can drive behavior change and move patients toward optimal care.